Clinical Implications of Emerging Data on the Safety of Proton Pump Inhibitors

@article{SchnollSussman2017ClinicalIO,
  title={Clinical Implications of Emerging Data on the Safety of Proton Pump Inhibitors},
  author={F. Schnoll-Sussman and P. Katz},
  journal={Current Treatment Options in Gastroenterology},
  year={2017},
  volume={15},
  pages={1-9}
}
Opinion statementProton pump inhibitors (PPI) are among the safest class of drugs used by all care providers, including gastroenterologists. They are the mainstay in treatment of acid-related disease, in particular, gastroesophageal reflux disease. Without them, many patients would experience a major decrement in their quality of life. However, no drug is without side effects or adverse events. In the past decade, numerous reports, principally case control studies and meta-analyses, have raised… Expand
29 Citations
Use of proton pump inhibitors and risk of ischemic events in the general population.
  • 6
  • PDF
Proton Pump Inhibitors Use and the Risk of Fatty Liver Disease; A Nationwide Cohort Study.
  • 1
Bowel symptoms in patients that receive proton pump inhibitors. Results of a multicenter survey in Mexico.
  • 5
Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth
  • 53
The relationship between proton pump inhibitors and renal disease
  • 6
  • PDF
Proton Pump Inhibitors Intake and Iron and Vitamin B12 Status: A Prospective Comparative Study with a Follow up of 12 Months
  • 10
Long-term Treatment With Proton Pump Inhibitors Is Effective in Children With Eosinophilic Esophagitis
  • 19
...
1
2
3
...

References

SHOWING 1-10 OF 58 REFERENCES
Long-term safety concerns with proton pump inhibitors.
  • 181
Systematic Review of the Risk of Enteric Infection in Patients Taking Acid Suppression
  • 547
Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
  • 384
  • PDF
...
1
2
3
4
5
...